Carl Zeiss Meditec Announces Milestone of 1 Million SMILE Procedures

October 6, 2017: By Jon Swedien
SMILE laser vision correction procedure

SMILE laser vision correction procedure

Carl Zeiss Meditec announced Sept. 28 that doctors performing laser vision correction surgery using the company’s small-incision lenticule extraction (SMILE) technology have now surpassed 1 million procedures worldwide.

SMILE is being performed regularly by more than 1,300 surgeons in over 65 countries, Zeiss said.

A flapless procedure, SMILE requires only one laser to perform the treatment. During SMILE, doctors correct patients’ refractive errors using the VisuMax femtosecond laser. With the laser, surgeons create a thin disc-shaped lenticule within the cornea, which is then removed through a small incision on the surface of the cornea, also created by the laser, thereby achieving the desired vision correction.

Because the procedure requires only a small incision, it leaves the outer corneal layer largely intact, thus potentially contributing to the cornea’s stability (both biomechanical and refractive) after surgery and to fast visual recovery, Zeiss said.

The company is based in Jena, Germany.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

US Health Secretary Alex Azar Takes Aim at Rebates in US Senate Hearing

Beyeonics Surgical Raises $11.5 Million in Initial Funding Round

MeiraGTx Raises $75 Million in Initial Public Offering

GenSight to Pursue Approval for LHON Gene Therapy Candidate, Despite Phase III Setback

Optovue Receives FDA Clearance for AngioAnalytics, First OCT Angiography Metrics

Nexy Robotic Retinal Imaging System Receives FDA Clearance

Ocutrx Receives US Patent for Oculenz AR Glasses for Macular Degeneration

Allergan’s Bimatoprost SR Demonstrates Noninferiority to Timolol in Phase III Glaucoma Study

KKR to acquire Envision Healthcare, Including Amsurg ASC Business

Ophthalmologist Carmen Puliafito, MD, Seeks to Regain Medical License

Avedro Gains J Code for Photrexa Formulations in Preliminary CMS Decision

EyeGate Seeks to Study Ocular Bandage Gel in Punctate Epitheliopathy

Nicox, Ironwood to Collaborate on Novel Ophthalmic Treatments

US FDA Approves MDGH’s Moxidectin for Treatment of River Blindness

Bausch + Lomb Enrolls First Patient in Trial for enVista MX60EF Trifocal IOL

Cincinnati Eye Institute Partners with Private Equity Firm to Pursue National Expansion

Ophthotech Enters Gene Therapy Deals with University of Florida, University of Pennsylvania

Teva’s Launches Generic Version of Restasis in Canada

Clearside’s Phase II Trial for DME Candidate Meets Primary Endpoint

Orasis Raises $13 Million in Series B Financing

Coming soon

2018 Optical Coherence Tomography Report: A Global Market Analysis for 2017 to 2023